CompaniesByCap
ORMP
Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ · Healthcare

Oramed Pharmaceuticals Inc. Cash Flow 2016–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Aug 2021Aug 2020Aug 2019Aug 2018Aug 2017Aug 2016Aug 2015Aug 2014Aug 2013Aug 2012Aug 2011
Operating Activities
Operating Cash Flow-9.1M-8.4M-10.3M-27.9M-21.2M-12.4M-12.9M-14.7M-5.8M4.7M-4.9M-4.1M-3.4M-2.3M-1.7M
Depreciation & Amort.
Investing Activities
Capital Expenditure9,00018,000254,000496,000375,00082,00015,0005,0007,0009,0001,00014,0006,0002,0002,180
Free Cash Flow-9.2M-8.4M-10.5M-28.4M-21.6M-12.5M-13.0M-14.7M-5.8M4.6M-4.9M-4.1M-3.4M-2.3M-1.7M
Financing Activities
Dividends Paid
Stock Buybacks4.7M2.5M

Oramed Pharmaceuticals Inc. Cash Flow — FAQ

Oramed Pharmaceuticals Inc. (ORMP) cash flow over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ORMP's cash flow history?

The chart and table above show Oramed Pharmaceuticals Inc.'s cash flow by year and by quarter, including the growth rate.